bf/NASDAQ:GILD_icon.png

NASDAQ:GILD

Gilead Sciences, Inc.

  • Stock

USD

Last Close

65.54

07/05 20:00

Market Cap

99.09B

Beta: 0.40

Volume Today

4.90K

Avg: 5.58M

PE Ratio

16.30

PFCF: 11.99

Dividend Yield

3.91%

Payout:48.14%

Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
1.90B
-
1.72B
9.44%
1.67B
2.93%
1.77B
6.02%
1.19B
32.58%
807.50M
32.37%
1.44B
78.39%
2.54B
76.36%
2.87B
13.13%
2.78B
3.38%
average payables
1.29B
-
1.11B
14.41%
1.07B
3.52%
1.19B
11.77%
1.01B
15.27%
802M
20.59%
751.50M
6.30%
778.50M
3.59%
774.50M
0.51%
805M
3.94%
average receivables
1.93B
-
3.37B
74.87%
5.24B
55.73%
5.18B
1.15%
4.18B
19.32%
3.59B
14.19%
3.45B
3.75%
4.24B
22.65%
4.69B
10.75%
4.63B
1.23%
book value per share
7.68
-
10.39
35.28%
13.06
25.61%
14.46
10.77%
15.69
8.47%
16.59
5.77%
17.83
7.50%
14.50
18.72%
16.77
15.69%
16.90
0.77%
capex per share
-0.12
-
-0.37
193.23%
-0.51
39.42%
-0.56
9.48%
-0.45
19.19%
-0.71
57.70%
-0.65
8.75%
-0.52
20.40%
-0.46
10.85%
-0.58
25.83%
capex to depreciation
-0.55
-
-0.53
4.15%
-0.68
28.25%
-0.65
5.05%
-0.46
28.97%
-0.65
40.94%
-0.59
9.12%
-0.44
25.26%
-0.28
35.69%
-0.35
22.57%
capex to operating cash flow
-0.06
-
-0.04
29.28%
-0.04
15.44%
-0.04
22.12%
-0.05
10.51%
-0.11
121.83%
-0.09
17.98%
-0.08
11.80%
-0.05
36.09%
-0.08
57.78%
capex to revenue
-0.02
-
-0.02
31.39%
-0.02
2.27%
-0.02
7.54%
-0.02
8.18%
-0.04
84.78%
-0.04
11.99%
-0.03
28.36%
-0.02
19.46%
-0.03
25.84%
cash per share
1.39
-
6.65
377.21%
9.98
49.94%
8.88
10.96%
19.52
119.71%
23.18
18.77%
19.17
17.28%
5.89
69.26%
5.19
11.92%
5.09
1.99%
days of inventory on hand
262.50
-
133.55
49.12%
178.13
33.38%
135.94
23.68%
66.89
50.80%
61.22
8.47%
161.38
163.60%
240.62
49.10%
151.18
37.17%
181.95
20.36%
days payables outstanding
160.37
-
92.02
42.62%
107.33
16.64%
103.31
3.75%
67.97
34.20%
59.42
12.59%
55.67
6.31%
67.38
21.04%
38.98
42.14%
58.39
49.79%
days sales outstanding
68.44
-
67.97
0.68%
65.46
3.69%
54.22
17.18%
53.84
0.69%
54.88
1.93%
58.24
6.12%
72.32
24.18%
60.06
16.96%
63.91
6.41%
debt to assets
0.18
-
0.34
93.54%
0.41
18.75%
0.44
7.04%
0.48
9.04%
0.43
10.09%
0.40
7.00%
0.46
15.03%
0.39
14.42%
0.40
1.67%
debt to equity
0.34
-
0.75
121.40%
1.11
46.98%
1.29
16.13%
1.64
27.04%
1.27
22.45%
1.09
14.42%
1.72
58.72%
1.27
26.46%
1.19
6.13%
dividend yield
0.02
-
0.04
194.39%
0.01
71.56%
0.03
102.40%
0.03
13.92%
0.04
25.46%
0.04
6.69%
0.05
20.63%
0.04
16.07%
0.03
12.91%
earnings yield
0.03
-
0.08
214.92%
0.12
44.91%
0.14
15.19%
0.05
64.90%
0.07
35.93%
0.07
2.86%
0.00
98.14%
0.07
5,516.54%
0.04
37.56%
0.06
31.47%
enterprise value
112.75B
-
133.45B
18.36%
135.29B
1.38%
114.00B
15.74%
119.59B
4.90%
90.57B
24.26%
95.49B
5.43%
98.64B
3.30%
112.56B
14.11%
127.56B
13.33%
enterprise value over ebitda
24.97
-
8.74
65.00%
6.05
30.73%
6.31
4.26%
8.16
29.35%
10.20
24.98%
15.51
52.03%
11.59
25.28%
11.90
2.68%
12.27
3.11%
ev to operating cash flow
36.31
-
10.41
71.33%
6.66
36.08%
6.84
2.77%
10.05
46.96%
10.78
7.28%
10.44
3.15%
12.08
15.64%
9.89
18.13%
14.06
42.21%
ev to sales
10.07
-
5.36
46.73%
4.15
22.69%
3.75
9.50%
4.58
22.11%
4.09
10.64%
4.25
3.91%
4.00
6.07%
4.12
3.18%
4.68
13.43%
free cash flow per share
1.91
-
8.06
322.56%
13.38
66.04%
11.89
11.11%
8.65
27.24%
5.76
33.43%
6.55
13.73%
5.98
8.69%
8.60
43.84%
6.65
22.71%
6.42
3.51%
free cash flow yield
0.03
-
0.09
236.67%
0.13
54.67%
0.17
25.61%
0.12
27.27%
0.09
23.75%
0.10
9.48%
0.10
1.84%
0.12
15.41%
0.08
34.63%
0.08
2.25%
graham net net
-3.94
-
-2.99
24.10%
-8.71
191.49%
-16.09
84.70%
-16.05
0.20%
-7.05
56.09%
-8.59
21.81%
-29.91
248.38%
-28.37
5.17%
-24.37
14.10%
graham number
18.65
-
43.12
131.24%
60.28
39.79%
57.28
4.98%
35.35
38.28%
39.61
12.04%
41.25
4.15%
4.81
88.35%
43.25
799.92%
37.30
13.75%
income quality
1.02
-
1.06
4.66%
1.12
5.63%
1.24
10.07%
2.56
107.31%
1.54
39.95%
1.70
10.81%
91.78
5,283.67%
1.84
98.00%
1.99
8.23%
intangibles to total assets
0.58
-
0.35
39.19%
0.22
37.64%
0.18
19.18%
0.30
69.91%
0.31
3.09%
0.29
6.83%
0.60
107.49%
0.61
2.02%
0.59
4.22%
0
100%
interest coverage
14.74
-
37.05
151.34%
32.26
12.94%
18.29
43.29%
12.63
30.93%
7.61
39.73%
4.31
43.41%
7.14
65.79%
7.40
3.57%
7.84
5.96%
-8.06
202.76%
interest debt per share
2.82
-
8.11
187.78%
14.95
84.26%
19.34
29.40%
26.52
37.09%
21.88
17.50%
20.15
7.91%
25.76
27.88%
22.05
14.41%
20.85
5.45%
inventory turnover
1.39
-
2.73
96.56%
2.05
25.02%
2.68
31.03%
5.46
103.24%
5.96
9.25%
2.26
62.06%
1.52
32.93%
2.41
59.17%
2.01
16.91%
invested capital
0.34
-
0.75
121.40%
1.11
46.98%
1.29
16.13%
1.64
27.04%
1.27
22.45%
1.09
14.42%
1.72
58.72%
1.27
26.46%
1.19
6.13%
market cap
114.80B
-
143.46B
24.97%
148.14B
3.26%
95.89B
35.27%
93.63B
2.35%
81.19B
13.29%
82.52B
1.64%
73.23B
11.26%
91.20B
24.53%
107.74B
18.14%
101.10B
6.16%
net current asset value
-4.03B
-
-1.10B
72.72%
1.29B
217.58%
867M
32.84%
-8.44B
1,073.01%
-6.49B
23.09%
-7.49B
15.41%
-34.37B
359.00%
-31.83B
7.38%
-26.73B
16.01%
net debt to ebitda
-0.45
-
-0.66
44.50%
-0.57
12.32%
1.00
274.46%
1.77
76.65%
1.06
40.35%
2.11
99.24%
2.99
41.77%
2.26
24.35%
1.91
15.57%
net income per share
2.01
-
7.95
295.26%
12.37
55.57%
10.08
18.48%
3.54
64.88%
4.20
18.69%
4.24
0.91%
0.07
98.33%
4.96
6,899.95%
3.66
26.17%
4.54
24.06%
operating cash flow per share
2.03
-
8.42
314.62%
13.89
64.88%
12.45
10.35%
9.10
26.87%
6.47
28.91%
7.20
11.26%
6.50
9.75%
9.06
39.48%
7.23
20.25%
6.42
11.26%
payables turnover
2.28
-
3.97
74.27%
3.40
14.26%
3.53
3.90%
5.37
51.98%
6.14
14.40%
6.56
6.74%
5.42
17.38%
9.36
72.85%
6.25
33.24%
receivables turnover
5.33
-
5.37
0.69%
5.58
3.83%
6.73
20.75%
6.78
0.70%
6.65
1.90%
6.27
5.77%
5.05
19.47%
6.08
20.42%
5.71
6.03%
research and ddevelopement to revenue
0.19
-
0.11
39.41%
0.09
19.47%
0.17
81.66%
0.14
14.74%
0.23
58.56%
0.41
78.86%
0.20
49.68%
0.20
3.77%
0.18
7.12%
0.21
15.59%
return on tangible assets
0.33
-
0.54
65.50%
0.45
17.00%
0.29
35.65%
0.09
67.25%
0.12
31.87%
0.12
1.05%
0.00
97.34%
0.24
7,163.84%
0.18
25.66%
revenue per share
7.33
-
16.35
123.17%
22.29
36.33%
22.70
1.80%
19.97
11.99%
17.05
14.66%
17.68
3.69%
19.64
11.12%
21.74
10.68%
21.74
0.01%
21.73
0.05%
roe
0.26
-
0.76
192.19%
0.95
23.85%
0.70
26.40%
0.23
67.62%
0.25
12.22%
0.24
6.13%
0.00
97.95%
0.30
5,950.35%
0.22
26.74%
roic
0.21
-
0.44
111.94%
0.46
4.06%
0.31
31.56%
0.09
71.53%
0.12
29.57%
0.09
19.73%
0.01
92.59%
0.11
1,562.81%
0.12
6.20%
sales general and administrative to revenue
0.15
-
0.12
21.00%
0.10
12.42%
0.11
6.52%
0.15
32.85%
0.18
23.40%
shareholders equity per share
7.68
-
10.39
35.28%
13.06
25.61%
14.46
10.77%
15.69
8.47%
16.59
5.77%
17.83
7.50%
14.50
18.72%
16.77
15.69%
16.90
0.77%
stock based compensation to revenue
0.02
-
0.01
35.70%
0.01
19.08%
0.01
6.84%
0.02
95.44%
0.04
56.27%
0.03
25.81%
0.03
8.07%
0.02
10.71%
0.02
0.40%
tangible asset value
-1.32B
-
3.57B
369.81%
7.69B
115.28%
9.22B
19.83%
-758M
108.22%
1.68B
321.50%
4.75B
182.73%
-23.01B
584.79%
-20.72B
9.95%
-16.00B
22.80%
tangible book value per share
-0.87
-
2.35
370.99%
5.26
123.81%
6.89
31.02%
-0.58
108.42%
1.29
323.04%
3.74
188.96%
-18.31
589.80%
-16.50
9.88%
-12.75
22.73%
working capital
401.14M
-
12.13B
2,923.66%
24.13B
98.91%
29.26B
21.29%
29.71B
1.53%
25.05B
15.69%
21.73B
13.25%
4.42B
79.66%
3.45B
22.02%
3.99B
15.79%

All numbers in USD (except ratios and percentages)